Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Frank

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|August 14, 2008
High-performance signal peptide prediction based on sequence alignment techniquesKarl Frank, Manfred J Sippl
Bioinformatics (Oxford, England)|January 19, 2010
COPS benchmark: interactive analysis of database search methodsKarl Frank, Markus Gruber, Manfred J Sippl
Structure (London, England : 1993)|June 24, 2014
Structure-based characterization of multiprotein complexesMarkus Wiederstein, Markus Gruber, Karl Frank, et al.
European Journal of Clinical Pharmacology|December 22, 2005
Evaluation of the effect of multiple-dose administration of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist on the major CYP isoform activities in healthy volunteersYoussef Hijazi, Horst Welker, Albert E Dorr, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2012
Pharmacokinetic/Pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitorsMicaela B Reddy, Peter N Morcos, Sophie Le Pogam, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Identification of N-acyl 4-(5-pyrimidine-2,4-dionyl)phenylalanine derivatives and their orally active prodrug esters as dual-acting alpha4-beta1 and alpha4-beta7 receptor antagonistsAchyutharao Sidduri, Jefferson W Tilley, Jianping Lou, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonistsJefferson W Tilley, Achyutharao Sidduri, Jianping Lou, et al.
Toxicologic Pathology|April 17, 2008
Temporal gene expression profiling indicates early up-regulation of interleukin-6 in isoproterenol-induced myocardial necrosis in ratIgor Mikaelian, Denise Coluccio, Kevin T Morgan, et al.
Journal of Medicinal Chemistry|December 11, 2012
3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo modelsMichael Soth, Johannes C Hermann, Calvin Yee, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|August 14, 2008
High-performance signal peptide prediction based on sequence alignment techniquesKarl Frank, Manfred J Sippl
Bioinformatics (Oxford, England)|January 19, 2010
COPS benchmark: interactive analysis of database search methodsKarl Frank, Markus Gruber, Manfred J Sippl
Structure (London, England : 1993)|June 24, 2014
Structure-based characterization of multiprotein complexesMarkus Wiederstein, Markus Gruber, Karl Frank, et al.
European Journal of Clinical Pharmacology|December 22, 2005
Evaluation of the effect of multiple-dose administration of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist on the major CYP isoform activities in healthy volunteersYoussef Hijazi, Horst Welker, Albert E Dorr, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2012
Pharmacokinetic/Pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitorsMicaela B Reddy, Peter N Morcos, Sophie Le Pogam, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Identification of N-acyl 4-(5-pyrimidine-2,4-dionyl)phenylalanine derivatives and their orally active prodrug esters as dual-acting alpha4-beta1 and alpha4-beta7 receptor antagonistsAchyutharao Sidduri, Jefferson W Tilley, Jianping Lou, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonistsJefferson W Tilley, Achyutharao Sidduri, Jianping Lou, et al.
Toxicologic Pathology|April 17, 2008
Temporal gene expression profiling indicates early up-regulation of interleukin-6 in isoproterenol-induced myocardial necrosis in ratIgor Mikaelian, Denise Coluccio, Kevin T Morgan, et al.
Journal of Medicinal Chemistry|December 11, 2012
3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo modelsMichael Soth, Johannes C Hermann, Calvin Yee, et al.
Pageof 1